Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Duration“
Suchtreffer
Begriffe & Kennungen
Gazyvaro · 4.8 · The study MO40597 was designed to characterize the safety profile of short duration infusions (approximately 9
Eintrag öffnenGazyvaro · 4.8 · c Patients received short-duration infusion from C2 onward. The denominator at C2 and subsequent cycles repres
Eintrag öffnenGobivaz · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGobivaz · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGobivaz · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGobivaz · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGotenfia · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGotenfia · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenGranpidam · 4.8 · The most common adverse reactions reported across the duration of the short-term and long-term studies were ge
Eintrag öffnenHBVaxPro · 4.8 · The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Eintrag öffnenHBVaxPro · 4.8 · The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Eintrag öffnenHBVaxPro · 4.8 · The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Eintrag öffnenHBVaxPro · 4.8 · The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Eintrag öffnenHBVaxPro · 4.8 · The most common side effects seen are injection-site reactions: transient soreness, erythema, induration.
Eintrag öffnenHalaven · 4.8 · 8 307/404 (76.0%) and 1314/1559 (84.3%), respectively. The median duration of treatment was 12.0 weeks for sar
Eintrag öffnenHefiya · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHefiya · 4.8 · During the controlled portions of pivotal adalimumab studies in adults of at least 12 weeks in duration in pat
Eintrag öffnenHefiya · 4.8 · In controlled Phase 3 studies of adalimumab in patients with plaque Psoriasis with a control period duration r
Eintrag öffnenHefiya · 4.8 · In controlled Phase 3 studies of adalimumab in patients with plaque Psoriasis with a control period duration r
Eintrag öffnenHemlibra · 4.8 · Average cumulative amount of aPCC over 24 hours Duration of aPCC (U/kg/24 hours) treatment <50 50–100 >100 <24
Eintrag öffnen